Physician profile
Dayna Morelli
NPI 1215790688
$4,295.03
in general payments reported to CMS, 2019-2025
36 companies · $2,760 in 2025
The $2,760 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,535 · 2025: $2,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,295.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $702.18 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $526.18 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $383.23 | 2024-2025 | Otezla, Otezla, Repatha |
| Esperion Therapeutics, INC. | $242.85 | 2024-2025 | Nexletol, Nexlizet |
| Abbvie INC. | $238.43 | 2024-2025 | |
| Antares Pharma, INC. | $214.36 | 2024-2025 | Xyosted |
| Novartis Pharmaceuticals Corporation | $177.76 | 2024-2025 | |
| Lundbeck LLC | $171.80 | 2025 | Rexulti |
| Boston Scientific Corporation | $147.44 | 2024-2025 | Watchman Flx |
| Exact Sciences Corporation | $143.47 | 2024-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $138.89 | 2024-2025 | Rexulti |
| Lilly USA, LLC | $128.51 | 2024-2025 | Zepbound, Mounjaro, Kisunla |
| Alk-Abello, INC | $119.91 | 2024-2025 | Ragwitek, Odactra, Grastek |
| Bayer Healthcare Pharmaceuticals INC. | $94.33 | 2024-2025 | |
| Abbott Laboratories | $76.88 | 2025 | Freestyle Libre 3 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dayna Morelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.